Skip to content
Search

Latest Stories

New pharmacy minister Neil O’Brien is warned he'll find the sector 'more fragile than ever'

Pharmacy bodies have welcomed the new minister in charge of the profession amid warnings that he will find the sector in a state that is "more fragile that ever" due to "untenable funding and workforce pressures".

Neil O’Brien was re-appointed as parliamentary under secretary of state in the Department of Health and Social Care (DHSC) on October 25 and was later assigned the pharmacy brief.


The Conservative MP for Harborough -- who will have a wide-ranging portfolio of responsibilities, including primary care and pharmacy -- has taken over the position from Will Quince MP, who had a brief stint as pharmacy minister but remains at the department on a different role.

O’Brien was was handed a junior minister's job at DHSC on 7 September 2022 in the government led by Liz Truss but fellow Conservative Quince was assigned primary care duties including pharmacy.

Welcoming him to his new role, The Company Chemists' Association said that the minister would find that the community pharmacy sector was "more fragile than ever" with untenable pressures over funding and workforce.

The CCA CEO Malcolm Harrison said: "The government must recognize that a real-terms cut in funding across the last eight years is leading to an increasing rate of permanent pharmacy closures. Our own research finds that 41 per cent of permanent closures since 2015 have occurred in the 20 per cent most deprived areas of England.

"The NHS must endeavor to put patients back in control. As such, a holistic review of primary care is urgently needed. This will ensure that resources are directed to where they deliver the most benefit to patients. Such a review must be underpinned by a fully funded and integrated workforce plan, as recommended by the Health and Social Care Committee”.

Dr Leyla Hannbeck, chief executive of the Association of Independent Multiple Pharmacies, said: “We welcome the appointment of Neil O’Brien MP and hope for a more stable and sustained period in administration. We are ready and willing to support minister O’Brien at a challenging and pivotal time for the NHS and community pharmacy.”

Chief executive of the Pharmaceutical Services Negotiating Committee, Janet Morrison, said: "We look forward to meeting with him at the earliest opportunity to continue our vital discussions on the very serious challenges facing the sector. We will also want to explore further the very valuable wider role that community pharmacy could play within primary care, with the right funding settlement and support.’’

Who is Neil O’Brien?

Mr O’Brien has been the Conservative MP for the West Midlands constituency since 2017 and was previously a special advisor to chancellor of the exchequer George Osborne from 2012 to 2016, and Theresa May during her tenure as prime minister.

He grew up in Huddersfield, West Yorkshire, where he was educated at All Saints High School and Greenhead College, before taking a first in philosophy, politics and economics at Christ Church, Oxford.

Prior to entering politics, Mr O'Brien conducted outreach work with homeless people and was a chair of school governors. He co-founded the think tank Onward.

Mr O'Brien lives in his Harborough constituency, and is married with two children.

According to government announcement, Mr O’Brien will have the following responsibilities as parliamentary under secretary of state at DHSC:

  • Primary Care:

    general practice

    pharmacy

    ophthalmology

    primary care backlogs

    primary care workforce

    50 million GP appointments

    dentistry

    prescription charges

    Blood, transplant and organs

  • UK Health Security Agency (UKHSA):

    COVID-19 – COVID-19 status certification, variant tracing, shielding

    environmental health (air quality, chemicals, radiation)

    health security at the border

    infectious diseases (including monkeypox)

    seasonal flu

  • Vaccines:

    COVID-19 vaccine deployment and uptake

    routine immunisations and vaccinations

  • Office for Health Improvement and Disparities (OHID):

    tobacco

    obesity

    alcohol, drugs and addiction

    NHS Health Checks

    children’s health, Start for Life

    sexual health

    long COVID

    antimicrobial resistance (AMR) and global health security

    emergency preparedness including Ukraine

  • Sponsorship of:

    NHS Blood and Transplant (NHSBT)

    UKHSA

    Food Standards Agency (FSA)

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less